BRESCIANI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 9.016
AS - Asia 5.330
EU - Europa 4.320
SA - Sud America 686
AF - Africa 107
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.473
Nazione #
US - Stati Uniti d'America 8.634
SG - Singapore 1.611
IT - Italia 1.300
VN - Vietnam 1.288
CN - Cina 1.061
DE - Germania 694
HK - Hong Kong 576
RU - Federazione Russa 533
BR - Brasile 510
CA - Canada 319
SE - Svezia 317
IE - Irlanda 310
GB - Regno Unito 240
UA - Ucraina 209
IN - India 174
FR - Francia 152
FI - Finlandia 134
AT - Austria 102
ID - Indonesia 89
KR - Corea 85
BD - Bangladesh 76
TR - Turchia 60
AR - Argentina 59
PL - Polonia 56
NL - Olanda 49
IQ - Iraq 47
BE - Belgio 42
JP - Giappone 42
ES - Italia 41
DK - Danimarca 38
MX - Messico 38
ZA - Sudafrica 34
CH - Svizzera 33
CO - Colombia 33
EC - Ecuador 29
PH - Filippine 29
PK - Pakistan 27
SA - Arabia Saudita 24
MY - Malesia 18
UZ - Uzbekistan 18
KE - Kenya 17
VE - Venezuela 15
MA - Marocco 12
PY - Paraguay 12
TW - Taiwan 12
BG - Bulgaria 11
CZ - Repubblica Ceca 11
CL - Cile 10
IR - Iran 10
LT - Lituania 9
RO - Romania 9
EG - Egitto 8
JM - Giamaica 8
LB - Libano 8
NP - Nepal 8
PS - Palestinian Territory 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
OM - Oman 7
TH - Thailandia 7
TN - Tunisia 7
UY - Uruguay 7
AU - Australia 6
CR - Costa Rica 6
KZ - Kazakistan 6
PE - Perù 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
EU - Europa 5
HN - Honduras 5
RS - Serbia 5
DZ - Algeria 4
EE - Estonia 4
ET - Etiopia 4
HU - Ungheria 4
PT - Portogallo 4
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
LY - Libia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SN - Senegal 3
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
NG - Nigeria 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
GA - Gabon 1
Totale 19.461
Città #
Ann Arbor 1.573
Singapore 999
Ashburn 846
Hong Kong 562
San Jose 512
Woodbridge 509
Wilmington 501
Frankfurt am Main 479
Chandler 445
Fairfield 436
Milan 405
Ho Chi Minh City 395
Hanoi 305
Dublin 299
Houston 257
Seattle 225
Beijing 218
New York 202
Jacksonville 191
Toronto 187
Dearborn 172
Los Angeles 163
Dallas 161
Santa Clara 151
Cambridge 137
Chicago 129
Princeton 112
Hefei 109
Vienna 90
The Dalles 88
Jakarta 78
Seoul 76
Council Bluffs 74
Nanjing 73
Rome 71
Helsinki 70
Buffalo 64
Lauterbourg 58
Shanghai 57
Moscow 56
Boardman 55
Da Nang 52
São Paulo 50
London 49
Altamura 45
Haiphong 45
Lawrence 42
Brussels 40
Munich 40
Guangzhou 39
Tokyo 36
Kent 33
Lachine 32
Warsaw 31
Biên Hòa 29
Orem 29
Nuremberg 28
Pune 28
San Diego 28
Fremont 27
Baghdad 24
Denver 23
Elora 23
Monza 23
Poplar 22
Ha Long 21
Nanchang 21
Andover 20
Brooklyn 20
Can Tho 20
Dong Ket 20
Hải Dương 19
Rio de Janeiro 19
Stockholm 19
Turin 19
Atlanta 18
Changsha 18
Shenyang 18
Tashkent 18
Turku 18
Detroit 17
Hebei 17
Montreal 17
San Francisco 17
Zurich 17
Romola 16
Amsterdam 15
Bari 15
Columbus 15
Johannesburg 15
Phoenix 15
Quận Bình Thạnh 15
Ankara 14
Carate Brianza 14
Thái Nguyên 14
Chennai 13
Jinan 13
Nairobi 13
Bắc Ninh 12
Kunming 12
Totale 12.992
Nome #
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 526
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 512
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 511
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 501
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 463
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 459
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 448
Growth hormone secretagogues and the regulation of calcium signaling in muscle 446
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 394
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 393
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 364
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 355
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 343
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 339
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 331
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 320
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 307
Feeding behavior during long-term hexarelin administration in young and old rats 306
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 306
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 306
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 305
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 303
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 300
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 298
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 297
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 293
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 293
Ghrelin in gastroenteric pathophysiology 291
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 288
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 288
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 284
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 283
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 282
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 281
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 280
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 279
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 273
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 272
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 272
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 272
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 267
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 256
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 254
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 253
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 251
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 249
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 248
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 244
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 239
Androgen therapy in neurodegenerative diseases 239
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 232
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 228
The role of androgens in women's health and wellbeing 224
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 219
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 213
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 212
La somatopausa: nuove prospettive terapeutiche 208
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 203
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 199
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 193
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 193
Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia 170
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 169
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 150
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 143
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 137
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 134
Role of nutrition in degenerative disease 107
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model 89
Anti-Inflammatory Effects of Progesterone on Human Microglia via TLR4/NLRP3 Pathway Modulation: Relevance to Drug-Resistant Epilepsy 19
Totale 19.888
Categoria #
all - tutte 59.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.033 116 109 121 83 56 75 46 46 30 86 96 169
2022/20231.866 186 484 216 182 142 268 31 118 115 19 56 49
2023/20241.156 38 58 67 77 134 281 218 52 74 23 21 113
2024/20252.808 153 234 213 189 234 166 220 133 168 376 237 485
2025/20267.769 1.294 689 578 780 809 361 1.008 313 616 608 372 341
Totale 19.888